11Dec
10Dec
Wasabi Technologies Announces Support in Japan for Veeam Backup for Microsoft Office 365
Wasabi Technologies, the hot cloud storage company, today announced validated interoperability with Veeam® Backup for Microsoft Office 365 with full support now available across the Asia-Pacific region. Veeam is the leader in backup, recovery and data management solutions that deliver modern data protection. Read more >>
10Dec
Legally blind Canadian using electronic glasses to develop more accessible apps
...Through the Canadian National Institute for Blindness’ (CNIB) scholarship program, Pope has been awarded the eSight 4, a wearable medical device developed by Toronto-based eSight. The organization was founded in 2006 by Canadian electrical engineer Conrad Lewis, who wanted to develop technologies that could aid his two legally blind sisters. Read more >>
10Dec
Disruptive tech for vision-impaired: Gregory Ogorek, COO & president of eSight
Vision impairment and blindness caused by diseases such as glaucoma and age-related macular degeneration (AMD) is a concern and potential threat to the economy for Asia, as the population is rapidly aging. eSight, a Canadian startup providing wearable devices to help restore or enhance the vision of people with low vision, is planning to expand to Asia by leveraging Taiwan as a platform for R&D and manufacturing for the region. Read more >>
09Dec
Pixability Hires Industry Veteran John Danby To Lead Its European Operations
Pixability (www.pixability.com), the only provider of software and insights for video advertising on YouTube, YouTube on TV, Amazon Fire, Roku, and Hulu today announces the appointment of John Danby as Managing Director of the company's European operations. The appointment comes at a time when Pixability's European business has grown considerably. Read more >>
09Dec
Hoth Therapeutics Licenses Lupus Therapeutic Back to Zylö Therapeutics
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs, is pleased to announce that it has entered into an agreement with Zylö Therapeutics to license its novel cannabinoid therapeutic, HT-005 for lupus patients, back to Zylö. Read more >>
09Dec
Zylö Therapeutics receives $300K investment from SC Launch
SC Launch Inc., South Carolina Research Authority (SCRA’s) investment affiliate, announced Dec. 7 it has invested $300,000 in Zylö Therapeutics Inc., a medical research business in Greenville. Read more >>
08Dec
Corbus Pharmaceuticals Appoints Rachael Brake, Ph.D., as Chief Scientific Officer
Corbus Pharmaceuticals Holdings, Inc. today announced the appointment of Rachael Brake, Ph.D., as Chief Scientific Officer, furthering the Company's mission of connecting innovation to purpose. Dr. Brake will build upon Corbus' commitment to immuno-oncology and joins the Company following the recent acquisition of monoclonal antibodies that inhibit TGFβ activation. Dr. Brake formerly held leadership roles at Takeda Oncology, including Vice President, Global Project Leader in the Oncology Therapeutic Area and Head, U.S. Medical Affairs, Oncology Business Unit. Read more >>
08Dec
ZetrOZ Proudly Continues Sponsorship of Connecticut Whale Women’s Ice Hockey
ZetrOZ Systems, developer of the sam® sustained acoustic medicine device, is proud to announce its continued support of Danbury's professional women's ice hockey team, the Connecticut Whale of the Premier Hockey Federation. For the second consecutive year, ZetrOZ is supporting the Whale and women's hockey with its wearable ultrasound technology that revolutionizes soft tissue injury healing. The ZetrOZ pain relief ultrasound device delivers long-duration slow-release ultrasound and promotes healing without the need for potentially addictive painkillers or invasive surgery. Read...
07Dec